NeuN+ neuronal nuclei in non-human primate prefrontal cortex and subcortical white matter after clozapine exposure

Schizophrenia Research
Tobias B HaleneSchahram Akbarian

Abstract

Increased neuronal densities in subcortical white matter have been reported for some cases with schizophrenia. The underlying cellular and molecular mechanisms remain unresolved. We exposed 26 young adult macaque monkeys for 6 months to either clozapine, haloperidol or placebo and measured by structural MRI frontal gray and white matter volumes before and after treatment, followed by observer-independent, flow-cytometry-based quantification of neuronal and non-neuronal nuclei and molecular fingerprinting of cell-type specific transcripts. After clozapine exposure, the proportion of nuclei expressing the neuronal marker NeuN increased by approximately 50% in subcortical white matter, in conjunction with a more subtle and non-significant increase in overlying gray matter. Numbers and proportions of nuclei expressing the oligodendrocyte lineage marker, OLIG2, and cell-type specific RNA expression patterns, were maintained after antipsychotic drug exposure. Frontal lobe gray and white matter volumes remained indistinguishable between antipsychotic-drug-exposed and control groups. Chronic clozapine exposure increases the proportion of NeuN+ nuclei in frontal subcortical white matter, without alterations in frontal lobe volumes or ce...Continue Reading

References

Feb 1, 1995·The American Journal of Psychiatry·S NybergL Bertilsson
May 10, 1994·Proceedings of the National Academy of Sciences of the United States of America·M S Lidow, P S Goldman-Rakic
Feb 13, 2001·Trends in Neurosciences·F M Benes, N Lange
Oct 11, 2001·Neurobiology of Disease·S AkbarianE G Jones
Oct 23, 2002·Human Brain Mapping·Stephen M Smith
Feb 5, 2003·International Journal of Clinical Pharmacology and Therapeutics·S UlrichF P Meyer
Sep 25, 2003·The Journal of Nervous and Mental Disease·Brian KirkpatrickRosalinda C Roberts
Jan 31, 2004·Progress in Neuro-psychopharmacology & Biological Psychiatry·Kenji IkedaKazuhiro Niizato
Apr 16, 2004·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Hui-Dong WangAriel Y Deutch
Apr 28, 2004·The American Journal of Pathology·Hideaki YokooYoichi Nakazato
Mar 10, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Karl-Anton Dorph-PetersenDavid A Lewis
Jun 9, 2005·Neurochemistry International·Liliána Z FehérAndrás Palotás
Sep 21, 2005·The New England Journal of Medicine·Jeffrey A LiebermanUNKNOWN Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators
Oct 26, 2006·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Glenn T KonopaskeDavid A Lewis
Apr 28, 2007·Epigenetics : Official Journal of the DNA Methylation Society·Karen N Thatcher, Janine M LaSalle
Sep 15, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Juan Torres-Reveron, Michael J Friedlander
Jun 30, 2009·Biological Psychiatry·Caroline M ConnorSchahram Akbarian
Jan 15, 2010·Journal of Neurochemistry·Matthew James GirgentiSamuel Sathyanesan Newton
Aug 10, 2010·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·Caroline M ConnorSchahram Akbarian
Oct 5, 2010·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·Ivica KostovićGoran Sedmak
Oct 29, 2010·Journal of Anatomy·Miloš JudašNataša Jovanov-Milošević
Aug 5, 2011·Journal of Neurochemistry·Robert SpoelgenArmin Schneider
Oct 5, 2011·Genes, Brain, and Behavior·O D IancuR Hitzemann
Apr 21, 2012·Briefings in Bioinformatics·Helga ThorvaldsdóttirJill P Mesirov

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here